The Motley Fool··David Jagielski, CpaHidden Bargains: Why These 'Expensive' Pharma Stocks Are Actually Undervalued
AbbVie and CVS Health appear costly on trailing metrics but trade at attractive forward multiples after accounting for non-recurring charges.
ABBVCVSvaluationdividend yield